South Africa gives twice-yearly HIV prevention jab the green light

South Africa has become the first African country, and only the third nation worldwide, to register a new twice-yearly HIV prevention jab.

It is believed the lenacapavir (LEN) injection could end HIV/Aids in the country within 14 to 18 years if enough people were able to take it.

The rapid approval of the LEN jab by the South African Health Products Regulatory Authority (Sahpra) opens the way for the health department to begin providing…